Generics Bulletin is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Perrigo Company PLC

http://www.perrigo.com/

Latest From Perrigo Company PLC

Tech Transfer Roundup: Athenex, PDS Align With National Cancer Institute On Oncology R&D

Athenex expands its portfolio of T-cell receptor therapy technology under NCI license agreement; PDS Biotechnology accesses institute’s TARP tumor antigen technology.

Tech Transfer Round-Up Deals

Consolidation And COVID See Off-Patent Industry Rankings Rewritten

After an extraordinary year that saw demand patterns and the supply chain upended by the COVID-19 pandemic, as well as a major merger that has transformed one of the global off-patent industry’s biggest players, Generics Bulletin’s Top 50 has once again seen significant changes.

Sales & Earnings Biosimilars

Consumer Health Changes ‘At Speed Of Instagram’ Drive J&J’s Decision On Separating Businesses

J&J provided color on plans for standalone consumer health business during a business overview with analysts. Multiple separation pathways are being considered.

Consumer M & A

Perrigo Suffers As It Waves Goodbye To Rx

Perrigo CEO Murray Kessler has acknowledged “disappointing” third quarter results for the company during a transitional quarter that saw it finally divest its Rx prescription generics business ahead of its upcoming acquisition of consumer healthcare specialist HRA Pharma.

Sales & Earnings Strategy
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Pharmaceuticals
    • Generic Drugs
    • Nutraceuticals
    • OTC, Consumer
  • Biotechnology
    • Drug Discovery Tools
      • Molecular Diversity
        • Natural Products
  • Other Names / Subsidiaries
    • Agis Industries
    • Chemagis
    • Clay-Park Labs
    • Cobrek Pharmaceuticals
    • Elan Corporation
    • JB Laboratories
    • Onclave Therapeutics Limited
    • Omega Pharma Invest N.V.
    • Paddock Laboratories
    • Omega Pharma Invest N.V.
    • Ranir Global Holdings LLC
    • Rosemont Pharmaceuticals Ltd.
    • Unico Holdings Inc.
    • Velcera, Inc.
    • Geiss, Destin & Dunn, Inc.
    • High Ridge Brands
UsernamePublicRestriction

Register